Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization

被引：65

作者：

Audouy, Sandrine A. L.

van Roosmalen, Maarten L.

Neef, Jolanda

Kanninga, Rolf

Post, Eduard

van Deemter, Marielle

Metselaar, Heidi

van Selm, Saskia

Robillard, George T.

Leenhouts, Kees J.

Hermans, Peter W. M.

机构：

[1] BiOMaDe Technol, NL-9747 AG Groningen, Netherlands

[2] UMC St Radboud, Lab Pediat Infect Dis, NL-6525 EN Nijmegen, Netherlands

来源：

VACCINE | 2006年 / 24卷 / 26期

关键词：

mucosal vaccine; Lactococcus lactis; gram-positive enhancer matrix (GEM); Streptococcus pneumoniae; SlrA; PpmA; IgA1; protease;

D O I：

10.1016/j.vaccine.2006.03.054

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The present work reports the use of non-living non-recombinant bacteria as a delivery system for mucosal vaccination. Antigens are bound to the cell-wall of pretreated Lactococcus lactis, designated as Gram-positive enhancer matrix (GEM), by means of a peptidoglycan binding domain. The influence of the GEM particles on the antigen-specific serum antibody response was studied. Following nasal immunization with the GEM-based vaccines, antibody responses were induced at systemic and local levels. Furthermore, different GEM-based vaccines could be used consecutively in the same mice without adverse effects or loss of activity. Taken together, the results evidence the adjuvant properties of the GEM particles and indicate that GEM-based vaccines can be used repeatedly and are particularly suitable for nasal immunization purposes. (c) 2006 Elsevier Ltd. All rights reserved.

引用

收藏

页码：5434 / 5441

页数：8

相关论文

共 36 条

[1] Development of antibodies against pneumococcal proteins α-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media [J].

Adrian, PV ;

Bogaert, DB ;

Oprins, M ;

Rapola, S ;

Lahdenkari, M ;

Kilpi, T ;

de Groot, R ;

Käyhty, H ;

Hermans, PWM .

VACCINE, 2004, 22 (21-22) :2737-2742

[2] Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate [J].

Bergquist, C ;

Lagergard, T ;

Holmgren, J .

INFECTION AND IMMUNITY, 1997, 65 (05) :1579-1583

[3] An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci [J].

Bermúdez-Humarán, LG ;

Cortes-Perez, NG ;

Le Loir, Y ;

Alcocer-González, JM ;

Tamez-Guerra, RS ;

de Oca-Luna, RM ;

Langella, P .

JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (05) :427-433

[4] Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine [J].

Berstad, AKH ;

Andersen, SR ;

Dalseg, R ;

Dromtorp, S ;

Holst, J ;

Namork, E ;

Wedege, E ;

Haneberg, B .

VACCINE, 2000, 18 (18) :1910-1919

[5] Immunoglobulin-A antibodies in upper airway secretions may inhibit intranasal influenza virus replication in mice but not protect against clinical illness [J].

Bizanov, G ;

Janakova, L ;

Knapstad, SE ;

Karlstad, T ;

Bakke, H ;

Haugen, IL ;

Haugan, A ;

Samdal, HH ;

Haneberg, B .

SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 61 (06) :503-510

[6] Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media [J].

Bogaert, D ;

Holmlund, E ;

Lahdenkari, M ;

de Groot, R ;

Kilpi, T ;

Hermans, PWM ;

Kayhty, H .

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2006, 46 (02) :166-168

[7] Novel surface display system for proteins on non-genetically modified gram-positive bacteria [J].

Bosma, T ;

Kanninga, R ;

Neef, J ;

Audouy, SAL ;

van Roosmalen, ML ;

Steen, A ;

Buist, G ;

Kok, J ;

Kuipers, OP ;

Robillard, G ;

Leenhouts, K .

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2006, 72 (01) :880-889

[8] Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection [J].

Brown, JS ;

Ogunniyi, AD ;

Woodrow, MC ;

Holden, DW ;

Paton, JC .

INFECTION AND IMMUNITY, 2001, 69 (11) :6702-6706

[9] A novel intranasal Protollin™-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice [J].

Chabot, S ;

Brewer, A ;

Lowell, G ;

Plante, M ;

Cyr, S ;

Burt, DS ;

Ward, BJ .

VACCINE, 2005, 23 (11) :1374-1383

[10] Mice immunization with live lactococci displaying a surface anchored HPV-16 E7 oncoprotein [J].

Cortes-Perez, NG ;

Bermúdez-Humarán, LG ;

Le Loir, Y ;

Rodriguez-Padilla, C ;

Gruss, A ;

Saucedo-Cárdenas, O ;

Langella, P ;

Montes-de-Oca-Luna, R .

FEMS MICROBIOLOGY LETTERS, 2003, 229 (01) :37-42

← 1 2 3 4 →